BD (Becton, Dickinson and Company), a global medical technology company with 70,000 employees, has acquired Tissuemed, a privately held firm headquartered in Leeds, that is an industry leader in developing self-adhesive surgical sealant films.
The acquisition of Tissuemed expands BD’s global offerings for surgeons outside of the United States.
Tissuemed’s lead product, Tissuepatch™, is a sealant technology that bonds to tissue to help control internal bleeding or prevent leaks from surgical incisions.
“This advanced sealant serves as a strategic complement to the BD products used in the operating room today — providing us with the opportunity to equip surgeons with a more robust, highly-integrated portfolio of surgical solutions,” said Kevin Kelly, president of Surgery for BD.
“Integrating Tissuepatch™ into our business aligns with our commitment to continuously innovate in our core portfolio to help support minimally invasive surgeries.”
Terms of the transaction were not disclosed.
